Objective. Exposure to illicit cocaine and its frequent adulterant, levamisole, is associated with ANCAs targeting neutrophil elastase (NE), neutropenia and vasculitic/thrombotic skin purpura. The mechanisms of cocaine/levamisole-associated autoimmunity (CLAA) are unknown. The aim of this study was to assess the ability of cocaine and levamisole to induce the release of neutrophil extracellular traps (NETs), a potential source of autoantigen and tissue injury.
Introduction
North America remains the world's largest market for illicit cocaine, with an estimated 1.5 million users in the USA alone [1] . A link between cocaine and autoimmunity was noted as early as 1996 with two reports of destructive upper airway lesions and serum ANCAs in cocaine users [2, 3] . In 2008, reports began to emerge of high-titre serum ANCAs, thrombotic/vasculitic skin purpura and severe neutropenia in cocaine users, a syndrome that coincided closely with the adulteration of the North American illicit cocaine supply with the anti-helminth drug, levamisole [4, 5] . By 2009, the US Centres for Disease Control were reporting that 69% of illicit cocaine seized in the USA contained levamisole [6] .
The mechanisms of cocaine/levamisole-associated autoimmunity (CLAA) and related clinical manifestations are unknown. Cocaine and levamisole have been independently linked to the development of ANCAs [5] . The antigen targets of ANCAs in cocaine users appear to be distinct from those in patients with idiopathic ANCA-associated vasculitis (AAV). In AAV, either MPO or PR3 is the dominant antigen target of ANCAs. In cocaine users, a dominant target of ANCAs is neutrophil elastase (NE) [5, 7] . NE is a chief enzymatic constituent of neutrophil extracellular traps (NETs), a recently recognized antimicrobial product released by activated neutrophils [8, 9] . NETs also play important pathogenic roles in certain inflammatory, autoimmune and thrombotic diseases [10, 11] . Formation of NETs (NETosis) is a type of neutrophil programmed cell death that results in extrusion of nuclear and/or mitochondrial DNA (mtDNA) mixed with granule contents. The antimicrobial, thrombotic and inflammatory properties of NETs appear to depend on their protein and nucleic acid composition, which itself is determined by the nature of stimulation [1113] . The idea that certain drugs might favour the development of highly immunogenic NETs was supported by a recent animal study of propylthiouracil-induced ANCA vasculitis [14] .
In AAV, IgG ANCA is believed to potentiate NETosis in activated neutrophils via binding externalized MPO and PR3 and simultaneous engagement of Fc receptors [15] , but a pathogenic role for ANCAs in CLAA has not been reported. Purpura and neutropenia have been attributed to toxic effects of levamisole, because therapeutic use of this drug can cause both manifestations [4] . Accordingly, purpura and neutropenia appear to be provoked by active or recent illicit cocaine use; and these problems abate with abstinence, despite the persistence of serum ANCAs (C. Lood and G. C. Hughes, unpublished observations). Thus, ANCA alone may not be sufficient to cause disease in cocaine users.
In this brief study, we identify two mechanisms that could contribute to the development of ANCAs and related clinical manifestations in cocaine users. First, cocaine and levamisole can induce the release of autoantigen in the form of NETs enriched in mtDNA. Second, ANCA from cocaine users enhances drug-induced NETosis, a potential mechanism linking acute drug exposure to certain clinical manifestations.
Methods
Patients and study approval Blood specimens from healthy control (HC) subjects were obtained with written donor consent according to the Declaration of Helsinki and with ethical approval of the University of Washington Institutional Review Board. For ANCA control (AC) and CLAA subjects, we obtained deidentified frozen serum samples that had been collected previously for the purpose of medical care. CLAA subjects had ANCA IF titres 51:256 and evidence of cocaine exposure by urine toxicology testing. AC subjects had ANCA IF titres 51:256 and no evidence of cocaine exposure by urine toxicology testing.
NET induction
Neutrophils were isolated from heparinized blood using Polymorphprep (Axis-Shield, Dundee, Scotland, UK). (1 mM; Sigma-Aldrich) for 1 h before addition of levamisole (10 nM), cocaine (10 mM) or PMA (20 nM) for an additional 4 h. In some experiments, serum IgG (10 mg/ml), purified using the Melon Gel IgG kit (Thermo Scientific), was added in combination with other stimuli.
NET quantification
Plate-bound NETs were detached for 30 min at 37 C with micrococcal nuclease (0.3 U/ml; Thermo Scientific), diluted in nuclease buffer containing 10 mM TrisHCl pH 7.5, 10 mM MgCl 2 , 2 mM CaCl 2 and 50 mM NaCl, and analysed by Sytox Green incorporation (Life Technology) as determined by fluorimetry (Synergy 2; BioTek, Winooski, VT, USA) using a DNA standard for quantification.
NET visualization
Activated neutrophils were fixed in 2% paraformaldehyde, permeabilized with saponin and stained with antibodies to NE (ab21595, diluted 1/100; Abcam, Cambridge, MA, USA) or purified human IgG (10 mg/ml) followed by addition of Alexa Fluor 555-conjugated donkey-anti-rabbit IgG (diluted 1/200; Invitrogen) or Alexa Fluor 647-conjugated donkey-anti-human IgG (diluted 1/1000; Jackson ImmunoResearch, West Grove, PA, USA), respectively, as well as DAPI or Sytox Green to identify DNA. NETs were visualized by IF microscopy (EVOS cell imaging system; Life Technology).
NE activity and protein levels
Detached NETs were incubated with NE substrate (N-succinyl-Ala-Ala-Ala-p-nitoranilide, 20 mM; Sigma-Aldrich), and absorbance was analysed at 405 nm (Synergy 2; BioTek). As a standard curve, purified porcine elastase was used (Sigma). Relative NE and DNA levels in NETs stained with DAPI and anti-NE (above) were quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Quantification of mtDNA DNA was purified from extruded NETs using phenol chloroform, and 8 ng of isolated DNA was mixed with SYBR green master mix (Thermo Scientific) and primers (50 nM) for 16S 
Results

Cocaine and levamisole induce NET formation
Upon exposure of neutrophils to cocaine or levamisole, we observed by IF microscopy release of DNA complexed with NE plus chromatin decondensation characteristic of NETs (Fig. 1A) . Drug concentrations used were those that yielded maximal NETosis (data not shown) and that fell within levels reported in human blood [16, 17] . Either drug could induce DNA release (Fig. 1B) , although not as potently as PMA. In these conditions, drug exposure resulted in only $20% cell death, whereas PMA, as expected, induced 100% cell death (data not shown). Despite lower DNA levels, drug-induced NETs showed similar NE activity compared with PMA-induced NETs ( Fig. 1C) , suggesting relative enrichment for NE. Indeed, material extruded after cocaine or levamisole exposure showed higher NE/DNA ratios compared with PMAinduced NETs (Fig. 1D) . Thus, drug-induced DNA release was qualitatively different from PMA-induced NETosis. To confirm that drug-induced DNA release was attributable to NETosis, we treated neutrophils with inhibitors of reactive oxygen species (ROS) production and peptidyl arginine deiminase, type 4 (PAD4)-mediated citrullination (Fig.  1E ). As expected, phorbol myristate acetate (PMA)-induced DNA release was reduced by inhibitors of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (apocynin) or PAD4 (Cl-amidine), but not by an inhibitor of mitochondrial ROS (mtROS), thenoyltrifluoroacetone. In contrast, drug-induced DNA release was somehwat reduced by all three of these inhibitors and almost completely abrogated by diphenyleneiodonium (DPI), an inhibitor of both NADPH oxidase and mtROS. Thus, cocaine and levamisole could induce DNA release through engagement of both mitochondrial and NADPH oxidase pathways. We recently demonstrated that production of mtROS primes neutrophils to release NETs enriched in oxidized, inflammatory mtDNA [13] . Consistent with a requirement for mtROS (Fig. 1E) , drug-induced NETs www.rheumatology.oxfordjournals.org contained higher ratios of 16S mtDNA/18S nuclear DNA compared with PMA-induced NETs (Fig. 1F) . Neutrophils are an important source of BAFF, a potent B-cell survival and differentiation factor implicated in the development of human autoimmunity [18] . We observed that both cocaine and levamisole enhanced the release of BAFF (Fig. 1G) , although not to the extent of PMA. In these experiments, we could not exclude the possibility that cell death pathways other than NETosis (e.g. apoptosis) contributed to BAFF release. Taken together, these results indicate that both cocaine and levamisole can induce in neutrophils the coincidental release of the following: (i) NETs enriched in potentially inflammatory mtDNA; (ii) NE, a major autoantigen in CLAA patients; and (iii) the B-cell survival factor, BAFF.
CLAA-IgG amplifies drug-induced NETosis and recognizes NET-associated antigens ANCA IgG from AAV patients can enhance TNFa-potentiated NETosis [15] . Therefore, we wanted to know whether ANCA IgG from CLAA subjects (CLAA-IgG) could enhance drug-induced NETosis. Although the addition of IgG purified from HC donors did not enhance NET formation induced by either drug, addition of ANCA control IgG (AC-IgG), and in particular CLAA-IgG, enhanced drug-induced DNA release by about 3-fold (Fig 2A and B) . None of the three IgG isolates was able to increase DNA release induced by PMA, a potent inducer of NETosis (Fig.  2C ). Thus, IgG purified from CLAA patients markedly enhanced cocaine-and levamisole-induced NET formation.
Given that both cocaine and levamisole could induce release of NET-associated NE (Fig. 1A and C) , and NE is a major antigen target of ANCAs in cocaine users, we wanted to know whether CLAA-IgG recognized NETassociated antigens. As expected, both AC-IgG and CLAA-IgG recognized cytoplasmic antigens in unstimulated neutrophils, whereas IgG from HC donors (HC-IgG) did not (Fig. 2E, upper row and insets) . In levamisole-stimulated neutrophils, however, CLAA-IgG, but not AC-IgG or HC-IgG, showed prominent reactivity with NET-associated antigens (Fig. 2E, bottom row) . The pattern of IgG staining was similar to that of NET-associated NE (Fig. 1A , cocaine or levamisole). Moreover, sera from CLAA but not AC or HC subjects showed marked IgG reactivity to NE (Fig. 2D) . Thus, it is likely that CLAA-IgG uniquely recognizes NE associated with drug-induced NETs.
Discussion
Our results identify potential mechanisms by which cocaine and its frequent adulterant, levamisole, break immunological tolerance in humans. Both drugs can induce formation of NETs enriched in NE, a known target of ANCAs in cocaine users. Moreover, druginduced NETs could be immunogenic owing to their relatively high content of inflammatory mtDNA, an idea that could be tested in animal models. Release of inflammatory NETs and NE in conjunction with BAFF might further promote the survival and differentiation of NE-reactive B cells. Indeed, IgG ANCAs in cocaine users can persist for years after apparent drug abstinence (C. Lood and G. C. Hughes, unpublished observations), suggesting the involvement of long-lived B cells having undergone immunoglobulin gene class switch recombination. Thus, chronic exposure to either drug may lead to loss of tolerance through repeated release of neutrophil antigens in the context of inflammatory DNA and BAFF. Whether or not cocaine and levamisole synergize in this regard remains to be determined.
However, ANCA alone appears insufficient to cause clinical disease in cocaine users; other factors, such as acute drug exposure, are required. Our observation that CLAA-IgG enhanced drug-induced NET formation suggests one way in which ANCAs could become pathogenic during acute drug exposure. For example, vasculitic purpura might involve ANCA enhancement of drug-induced NETosis among perivascular or tissue-infiltrating neutrophils, analogous to what is described in AAV [15] . Thrombotic purpura might involve the ability of NETs to cause intravascular thrombosis [10] . Additionally, binding of CLAA-IgG to drug-induced NETs might enhance their immunogenicity/pathogenicity by protecting them against degradation or by triggering complement-or Fc receptormediated inflammation, similar to mechanisms described for anti-NET antibodies in SLE [19] .
Continued study of CLAA is important for several reasons. First, millions of people may be at risk. Second, CLAA is likely to be more prevalent among cocaine users than suggested by available data, because only those presenting with select clinical manifestations are tested for autoimmunity; thus, CLAA may be a relatively common form of autoimmunity. Further dissecting its mechanisms should provide much needed insight into drug-induced autoimmunity, idiopathic AAV and other forms of immunological disease involving NETs.
